Twist Bioscience company profile

TWST · NASDAQ · USD

Compare Twist Bioscience
$104.78Change from previous close: −6.12%Absolute change: −$6.82

Close · November 16, 2026

Company profile

Twist Bioscience has 979 employees and is headquartered in South San Francisco, United States.

Pharmaceutical and biotech companies, academic laboratories, diagnostics developers, and agricultural and industrial chemical firms are the main customers of this synthetic DNA producer. Its offering includes synthetic genes and gene fragments, oligo pools, antibody libraries, next-generation sequencing library preparation kits and target panels, as well as synthetic viral controls and research panels for respiratory viruses, including SARS-CoV-2. Revenue by region in the fiscal year ended September 2025 was 59.9% from the Americas, 33.0% from EMEA and 7.1% from Asia Pacific.

In the fiscal year ended September 30, 2025, revenue reached 376.6 million US dollars, up 20.3% from the previous year, while the company posted a net loss of 77.7 million US dollars. The company was founded in 2013 and employs 979 people. Its headquarters are in South San Francisco, California, United States.

Company facts

Industry
Biotechnology
Headquarters
681 Gateway Boulevard, 94080, South San Francisco
Employees
979
Chief executive
Emily Leproust
Founded
2013
Fiscal year
October - September
Listing
TWST · NASDAQ
Currency
USD
ISIN
US90184D1000

Twist Bioscience and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Twist BioscienceTWSTUnited States$7.4B979-28.8%—
Corcept TherapeuticsCORTUnited States$9.36B7300.8%190.2
ImmunityBioIBRXUnited States$6.4B684-150.2%—
Madrigal PharmaceuticalsMDGLUnited States$9.93B915-10.7%—
BioMarin PharmaceuticalBMRNUnited States$11.09B3,22116.3%146.8
Summit TherapeuticsSMMTUnited States$11.32B2650.0%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Twist Bioscience with its competitors